380 related articles for article (PubMed ID: 28454983)
1. Emerging pharmacotherapies for alcohol use disorder.
Mason BJ
Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983
[TBL] [Abstract][Full Text] [Related]
2. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
3. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob GF
Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
[TBL] [Abstract][Full Text] [Related]
4. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.
Koob GF; Mason BJ
Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207
[TBL] [Abstract][Full Text] [Related]
5. Addiction as a stress surfeit disorder.
Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
[TBL] [Abstract][Full Text] [Related]
6. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.
Koob GF
Curr Top Behav Neurosci; 2013; 13():3-30. PubMed ID: 21744309
[TBL] [Abstract][Full Text] [Related]
7. Alcoholism: allostasis and beyond.
Koob GF
Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
[TBL] [Abstract][Full Text] [Related]
8. Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder.
Koob GF; Vendruscolo L
Curr Top Behav Neurosci; 2023 Jul; ():. PubMed ID: 37421551
[TBL] [Abstract][Full Text] [Related]
9. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Heilig M; Egli M; Crabbe JC; Becker HC
Addict Biol; 2010 Apr; 15(2):169-84. PubMed ID: 20148778
[TBL] [Abstract][Full Text] [Related]
10. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
Koob GF
Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
[TBL] [Abstract][Full Text] [Related]
11. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.
Koob GF
Biol Psychiatry; 2020 Jan; 87(1):44-53. PubMed ID: 31400808
[TBL] [Abstract][Full Text] [Related]
12. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
Koob GF; Colrain IM
Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199
[TBL] [Abstract][Full Text] [Related]
13. Neurobiological substrates for the dark side of compulsivity in addiction.
Koob GF
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):18-31. PubMed ID: 18725236
[TBL] [Abstract][Full Text] [Related]
14. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
Koob GF; Zorrilla EP
Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160
[TBL] [Abstract][Full Text] [Related]
15. Neurocircuitry of addiction.
Koob GF; Volkow ND
Neuropsychopharmacology; 2010 Jan; 35(1):217-38. PubMed ID: 19710631
[TBL] [Abstract][Full Text] [Related]
16. Neurobiology of addiction. Toward the development of new therapies.
Koob GF
Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
[TBL] [Abstract][Full Text] [Related]
17. Neuroclinical Framework for the Role of Stress in Addiction.
Kwako LE; Koob GF
Chronic Stress (Thousand Oaks); 2017 Feb; 1():. PubMed ID: 28653044
[TBL] [Abstract][Full Text] [Related]
18. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.
Matzeu A; Terenius L; Martin-Fardon R
Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880
[TBL] [Abstract][Full Text] [Related]
19. Neurobiology of addiction: a neurocircuitry analysis.
Koob GF; Volkow ND
Lancet Psychiatry; 2016 Aug; 3(8):760-773. PubMed ID: 27475769
[TBL] [Abstract][Full Text] [Related]
20. Influence of stress associated with chronic alcohol exposure on drinking.
Becker HC
Neuropharmacology; 2017 Aug; 122():115-126. PubMed ID: 28431971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
